North East and North Cumbria
ICS Formulary
ICS Formulary
5 Infections
05-03-03-01 Chronic hepatitis B
| Adefovir Dipivoxil Hepsera® |
|
Formulary
|
|
 NICE CG165: Hepatitis B (chronic) - incorporates TA96 NICE TA96: Hep B - adefovir dipivoxil and pegylated interferon alpha-2a |
|
| Entecavir |
|
Formulary
|
|
NICE CG165: Hepatitis B (incorporates TA153) NICE TA153: Hepatitis B (chronic) - etecavir |
|
|
| Lamivudine |
|
Formulary
|
|
NICE CG165: Chronic Hepatitis B |
|
|
| Tenofovir Disproxil Viread® |
|
Formulary
|
|
NICE CG165: Hepatitis B (incorporates TA153) NICE TA173: Hepatitis B (chronic) - tenofovir disoproxil |
|
|
Links
- COVID-19 Therapeutic Alert
- Interim Clinical Commissioning Policy: Antivirals or neutralising monoclonal antibodies in the treatment of COVID-19 in hospitalised patients (Version 5 - effective from 10th February 2022)
NENC ICB - Cellulitis Diagnosis and Management in Ambulatory Adults in primary care; Supporting Information- NICE CG165: Chronic Hepatitis B
- NICE CG165: Hepatitis B (chronic) - incorporates TA96
- NICE CG165: Hepatitis B (incorporates TA153)
- NICE CG165: Hepatitis B (incorporates TA153)
- NICE NG15: Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use
- NICE NG63: Antimicrobial stewardship: changing risk-related behaviours in the general population
- NICE TA153: Hepatitis B (chronic) - etecavir
- NICE TA173: Hepatitis B (chronic) - tenofovir disoproxil
- NICE TA96: Hep B - adefovir dipivoxil and pegylated interferon alpha-2a
- North of Tyne, Gateshead and North Cumbria - Antibiotic and Diagnostic quick reference tools
- Primary Care Antimicrobial Guidelines
- TEWV: Antibiotic Prescribing Procedure
- UK Interim Clinical Commissioning Police - Therapies for patients with symptomatic hospital-onset COVID-19